We are pleased to announce the signing of an agreement on March 11, 2025, to acquire the assets of the Life Science unit of Voden Medical Instruments S.p.A. This unit focuses on diagnostics, cellular and molecular biology as well as genome analysis and distributes our GenDx line of products in Italy.

These strategic acquisitions strengthen our presence in Italy and enable the seamless commercial integration of our proprietary products. 𝐖𝐞 𝐥𝐨𝐨𝐤 𝐟𝐨𝐫𝐰𝐚𝐫𝐝 𝐭𝐨 𝐧𝐞𝐰 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐚𝐧𝐝 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐝 𝐠𝐫𝐨𝐰𝐭𝐡!

#EurobioScientificGroup #Oncology #Voden